Prognostic and Diagnostic Significance of β-Catenin Nuclear Immunostaining in Colorectal Cancer

Clinical Cancer Research

Volumn 10, Issue 4, 2004, Pages 1401-1408

  Wong, Sze Chuen Cesar ^b   Lo, Elena Siu Fong ^c   Lee, King Chung ^c   Chan, John K C ^c   Hsiao, W L Wendy ^a,b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURVIVAL; CELL NUCLEUS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON POLYP; COLORECTAL CARCINOMA; CYSTADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; OVARY ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RECTUM ADENOMA; RECTUM CARCINOMA; RECTUM POLYP; SCORING SYSTEM; STOMACH ADENOCARCINOMA; TUMOR GROWTH;

ADENOMA; ANTIBODIES, MONOCLONAL; BETA CATENIN; CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOPLASM; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; PROGNOSIS; TRANS-ACTIVATORS; TREATMENT OUTCOME;

EID: 1642405321     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0157-03     Document Type: Article

References (42)

1. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
2. Polakis, P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta, 1332: 127-147, 1997.
3. Goss, K. H., and Groden, J. Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol., 18: 1967-1979, 2000.
4. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H. Joslyn, G., Stevens, J., Spirio, L., and Robertson, M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
5. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., and Hedge, P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (Wash. DC), 253: 665-669, 1991.
6. Willert, K., and Nusse, R. β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev., 8: 95-102, 1998.
7. Morin, P. J. β-catenin signaling and cancer. Bioessays, 21: 1021-1030, 1999.
8. Ben-Ze'ev, A. The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction. Ann. N. Y. Acad. Sci., 886: 37-47, 1999.
9. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawal, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
10. Chen, R. H., Ding, W. V., and McCormick, F. Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3β inhibition and activation of protein kinase C. J. Biol. Chem., 275: 17894-17899, 2000.
11. Kitaeva, M. N., Grogan, L., Williams, J. P., Dimond, E., Nakahara, K., Hausner P., DeNobile, J. W., Soballe, P. W., and Kirsch, I. R. Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res., 57: 4478-4481, 1997.
12. Iwao, K., Nakamori, S., Kameyama, M., Imaoka, S., Kinoshita, M., Fukui, T., Ishiguro, S., Nakamura, Y., and Miyoshi, Y. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res., 58: 1021-1026, 1998.
13. Inomata, M., Ochiai, A., Akimoto, S., Kitano, S., and Hirohashi, S. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res., 56: 2213-2217, 1996.
14. Valizadeh, A., Karayiannakis, A. J., El-Hariry, I., Kmiot, W., and Pignatelli, M. Expression of E-cadherin-associated molecules (α-, β- and γ-catenins and p120) in colorectal polyps. Am. J. Pathol., 150: 1977-1984, 1997.
15. Samowitz, W. S., Slattery, M. L., Potter, J. D., and Leppert, M. F. BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am. J. Pathol., 154: 1637-1641, 1999.
16. Kobayashi, M., Honma, T., Matsuda, Y., Suzuki, Y., Narisawa, R., Ajioka, Y., and Asakura, H. Nuclear translocation of β-catenin in colorectal cancer. Br. J. Cancer, 82: 1689-1693, 2000.
17. Miettinen, M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod. Pathol., 8: 384-388, 1995.
18. Tot, T. Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer (Phila.), 85: 171-177, 1999.
19. Wang, N. P., Zee, S., Zarbo, R. J., Bacchi, C. E., and Gown, A. M. Coordinate expression of cytokeratins 7 and 20 defined unique subsets of carcinomas. Appl. Immunohistochem., 3: 99-107, 1995.
20. Moll, R. Cytokeratins in the histological diagnosis of malignant tumors. Int. J. Biol. Markers, 9: 63-69, 1994.
21. Sack, M. J., and Roberts, S. A. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn. Cytopathol., 16: 132-136, 1997.
22. Chan, J. K., Suster, S., Wenig, B. M., Tsang, Y. W., Chan, J. B., and Lau, A. L. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am. J. Surg. Pathol., 21: 226-234, 1997.
23. Wong, S. C., Chan, J. K., Lee, K. C., and Hsiao, W. L. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J. of Pathol., 194: 35-42, 2001.
24. Mauri, F. A., Caffo, O., Veronese, S., Verderio, P., Boracchi, P., Bonzanini, M., Rossi, N., Perrone, G., Dalla Palma, P., and Barbareschi, M. Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up. Br. J. Cancer, 77: 1661-1668, 1998.
25. Remmele, W., and Schicketanz, K. H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs subjective grading IRS. Pathol. Res. Pract., 189: 862-866, 1993.
26. Saegusa, M., Hashimura, M., Hara, A., and Okayasu I. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors. J. Pathol., 190: 554-563, 2000.
27. Baillie, R., Carlile, J., Pendleton, N., and Schor, A. M. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer. J. Clin. Pathol., 54: 116-120, 2001.
28. Heideman, D. A., Snijders, P. J., Bloemena, E., Meijer, C. J., Offerhaus, G. J., Meuwissen, S. G., Gerritsen, W. R., and Craanen, M. E. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J. Pathol., 194: 428-435, 2001.
29. Hao, X., Tomlinson, I., Ilyas, M., Palazzo, J. P., and Talbot, I. C. Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumours. Virchows Arch., 431: 167-172, 1997.
30. Schlemper, R. J., Itabashi, M., Kato, Y., Lewin, K. J., Riddell, R. H., Shimoda, T., Sipponen, P., Stolte, M., and Watanabe, H. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (Phila.), 82: 60-69, 1998.
31. Hao, X. P., Pretlow, T. G., Rao, J. S., and Pretlow, T. P. β-Catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61: 8085-8088, 2001.
32. Novak, A., Hsu, SC., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., Roskelley, C., Grosschedl, R., and Dedhar, S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl. Acad. Sci. USA, 95: 4374-4379, 1998.
33. Bienz, M., and Clevers, H. Linking colorectal cancer to Wnt signaling. Cell, 103: 311-320, 2000.
34. Cheah, P. Y., Choo, P. H., Yao, J., Eu, K. W., and Seow-Choen, F. A. survival-stratification model of human colorectal carcinomas with β-catenin and p27kip1. Cancer (Phila.), 95: 2479-86, 2002.
35. Back, W., Loff, S., Jenne, D., and Bleyl, U. Immunolocalization of β-catenin in intestinal polyps of Peutz-Jeghers and juvenile polyposis syndromes. J. Clin. Pathol., 52: 345-349, 1999.
36. Spigelman, A. D., Murday, V., and Phillips, R. K. Cancer and the Peutz Jeghers syndrome. Gut, 30: 1588-1590, 1989.
37. Wu, T. T., Rezai, B., Rashid, A., Luce, M. C., Cayouette, M. C., Kim, C., Sani, N., Mishra, L., Moskaluk, C. A., Yardley, J. H., and Hamilton, S. R. Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am. J. Pathol., 150: 939-947, 1997.
38. Fenoglio-Preiser, C. M. When is a hyperplastic polyp not a hyperplastic polyp? Am. J. Surg. Pathol., 23: 1001, 1999.
39. Furlan, D., Tibiletti, M. G., Taborelli, M., Albarello, L., Cornaggia, M., and Capella, C. The value of microsatellite instability in the detection of HNPCC families and of sporadic colorectal cancers with special biological features: an investigation on a series of 100 consecutive cases. Ann. Oncol., 9: 901-906, 1998.
40. Salahshor, S., Kressner, U., Pahlman, L., Glimelius, B., Lindmark, G., and Lindblom, A. Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer, 26: 247-252, 1999.
41. Wong, N. A., Morris, R. G., McCondochie, A., Bader, S., Jodrell, D. I., and Harrison, D. J. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on β-catenin protein dysregulation, but not k-ras mutation. J. Pathol., 197: 128-135, 2002.
42. Jass, J. R., Barker, M., Fraser, L., Walsh, M. D., Whitehall, V. L., Gabrielli, B., Young, J., and Leggett, B. A. APC mutation and tumour budding in colorectal cancer. J. Clin. Pathol., 56: 69-73, 2003.